← Leaderboards
Newton E Hyslop
Tulane University Of Louisiana
$54,429
Attributed
$54,429
Total exposure
9
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.8K · FY2005–06$5K$3.8K$2.5K$1.3K$0
'05
'06
Funding mix
By agency
NIH$54,429 · 9
By mechanism
M01$54,429 · 9
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Juan J. L. Lertora$4,837,795
- Russell Barrett Van Dyke$24,377,705
- Krishna C. Agrawal$4,163,313
- David M Muschatt$847,086
- Debasis Mondal$1,002,333
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHiv InfectionsHuman Therapy EvaluationAids TherapyCombination ChemotherapyLamivudineHuman Immunodeficiency Virus 1Clinical Trial Phase ISaquinavirDrug Adverse EffectAntiaids AgentDrug Screening /EvaluationProtease InhibitorReverse Transcriptase InhibitorsVirus RnaStavudineZidovudineAmphotericin BBlood BanksCandidiasisDrug InteractionsFluconazoleIndinavir
Grant awards (16)
BLOOD COLLECTION FROM HEALTHY CONTROL INDIVIDUALS FOR IMMUNE STUDIES/VIRAL CULT$4,836
M01 · FY2006 · RR · contact PI
BLOOD COLLECTION FROM HEALTHY CONTROL INDIVIDUALS FOR IMMUNE STUDIES/VIRAL CULT$3,282
M01 · FY2005 · RR
BLOOD COLLECTION FROM HEALTHY CONTROL INDIVIDUALS$1,591
M01 · FY2004 · RR
NV15355C:SAQUINAVIR + 2 NUCLEOSIDE ANTIRETROVIRAL DRUGS IN HIV INFECT$0
M01 · FY2001 · RR
PFIZER R 0437:STUDY OF FLUCONAZOLE + AMPHOTERICIN B IN TREATMENT OF C$0
M01 · FY2001 · RR
CNAA &B3005:3TC &ZDV &1592U89 &3TC &ZDV &IDV IN HIV 1 INFECTED$0
M01 · FY2001 · RR
MKC-442 PLUS VIRACEPT IN HIV INFECTION$0
M01 · FY2001 · RR
COMBINATION ANTIRETROVIRAL THERAPIES FOR HIV INFECTION$0
M01 · FY2001 · RR
FORTOVASE ROLL-OVER PROTOCOL FOR HIV+ ADULTS$0
M01 · FY2001 · RR
CNAA &B3005:3TC &ZDV &1592U89 &3TC &ZDV &IDV IN HIV 1 INFECTED$11,180
M01 · FY2000 · RR
NV15355C:SAQUINAVIR + 2 NUCLEOSIDE ANTIRETROVIRAL DRUGS IN HIV INFECT$11,180
M01 · FY2000 · RR
BLOOD COLLECTION FROM NORMAL HEALTHY CONTROL INDIVIDUALS FOR IMMUNE STUDIES$11,180
M01 · FY2000 · RR
PFIZER R 0437:STUDY OF FLUCONAZOLE + AMPHOTERICIN B IN TREATMENT OF C$11,180
M01 · FY2000 · RR
COMBINATION ANTIRETROVIRAL THERAPIES FOR HIV INFECTION$0
M01 · FY2000 · RR
MKC-442 PLUS VIRACEPT IN HIV INFECTION$0
M01 · FY2000 · RR
FORTOVASE ROLL-OVER PROTOCOL FOR HIV+ ADULTS$0
M01 · FY2000 · RR